Kabra Drugs informs about outcome of board meeting

02 Sep 2021 Evaluate

Kabra Drugs has informed that the board of directors of the Company at its meeting held on 2nd September 2021 has approved that 32nd Annual General meeting of the company shall be held on 30th September 2021 and notice convening same was also approved by Board; to appoint a director in place of Ananthkumar Shilpa (Din No. 08677992) who retires by rotation, and being eligible, offers himself for re-appointment; to appoint a director in place of Bangalore Rajeevalochana Prasanna (Din No. 08680771) who retires by rotation, and being eligible, offers himself for re-appointment. Board further resolved that pursuant to the sections of the Companies Act, 2013 (including any statutory modification or re-enactment thereof, for the time being in force) and all the other applicable provisions, if any of the Companies, Act 2013 the Registered office of the company is shifted from 270 Shastri Market Indore Indore Indore MP 452007 IN to 'Kabra Drugs Ltd, No:1, First Floor, 3rd Cross Street, 3rd Main Road, Jaganatha Puram, Velachery, Chennai - 600 042.

The above information is a part of company’s filings submitted to BSE.

Kabra Drugs Share Price

28.80 -0.60 (-2.04%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×